Yousif Capital Management LLC acquired a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 31,347 shares of the company's stock, valued at approximately $1,214,000.
Other hedge funds have also recently bought and sold shares of the company. Lisanti Capital Growth LLC bought a new position in BrightSpring Health Services in the 3rd quarter valued at $1,959,000. Federated Hermes Inc. boosted its position in BrightSpring Health Services by 44.8% in the 3rd quarter. Federated Hermes Inc. now owns 319,200 shares of the company's stock valued at $9,436,000 after buying an additional 98,745 shares during the last quarter. Prescott Group Capital Management L.L.C. bought a new position in BrightSpring Health Services in the 3rd quarter valued at $887,000. Ellsworth Advisors LLC bought a new position in BrightSpring Health Services in the 3rd quarter valued at $983,000. Finally, Bailard Inc. bought a new position in BrightSpring Health Services in the 3rd quarter valued at $378,000.
Analyst Ratings Changes
A number of research analysts have commented on the company. UBS Group increased their price objective on BrightSpring Health Services from $53.00 to $55.00 and gave the company a "buy" rating in a research report on Wednesday, March 18th. BMO Capital Markets restated an "outperform" rating and issued a $46.00 price target on shares of BrightSpring Health Services in a research report on Friday, January 23rd. Zacks Research upgraded BrightSpring Health Services from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, March 3rd. Morgan Stanley raised their price target on BrightSpring Health Services from $40.00 to $48.00 and gave the stock an "overweight" rating in a research report on Wednesday, March 4th. Finally, BTIG Research restated a "buy" rating and issued a $55.00 price target on shares of BrightSpring Health Services in a research report on Thursday, March 19th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $45.50.
Read Our Latest Stock Analysis on BrightSpring Health Services
Insider Buying and Selling
In related news, CFO Jennifer A. Phipps sold 35,000 shares of the firm's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $1,440,250.00. Following the sale, the chief financial officer owned 196,840 shares of the company's stock, valued at approximately $8,099,966. This trade represents a 15.10% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jon B. Rousseau sold 220,000 shares of the firm's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $9,053,000.00. Following the sale, the insider directly owned 1,023,880 shares in the company, valued at $42,132,662. The trade was a 17.69% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 285,000 shares of company stock valued at $11,727,750. 3.40% of the stock is owned by company insiders.
BrightSpring Health Services Stock Performance
Shares of BrightSpring Health Services stock opened at $46.01 on Thursday. The company has a market capitalization of $8.89 billion, a PE ratio of 52.28, a PEG ratio of 0.61 and a beta of 2.03. BrightSpring Health Services, Inc. has a 12 month low of $15.48 and a 12 month high of $46.72. The company has a current ratio of 1.57, a quick ratio of 1.12 and a debt-to-equity ratio of 1.32. The stock's fifty day simple moving average is $41.73 and its 200 day simple moving average is $37.36.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, February 27th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.01). The business had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.38 billion. BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.The business's quarterly revenue was up 29.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.11 EPS. On average, research analysts predict that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services NASDAQ: BTSG is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company's operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.
Through its network of subsidiary brands, BrightSpring offers integrated care in the patient's home environment, fostering independence and improving quality of life.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report